In a filing, Avanos Medical Inc revealed its SVP, Chief Commercial Officer Holbrook Kerr unloaded Company’s shares for reported $0.11 million on Mar 06 ’25. In the deal valued at $15.25 per share,7,000 shares were sold. As a result of this transaction, Holbrook Kerr now holds 82,047 shares worth roughly $1.0 million.
Then, Holbrook Kerr bought 7,000 shares, generating $106,780 in total proceeds.
KeyBanc Capital Markets downgraded its Avanos Medical Inc [AVNS] rating to a Sector weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including CL King’s analysts, who began to cover the stock in late May with a ‘”a Buy”‘ rating. Stephens also remained covering AVNS and has decreased its forecast on August 04, 2021 with a “an Equal-weight” recommendation from previously “an Overweight” rating. Barclays revised its rating on April 13, 2020. It rated AVNS as “an Equal weight” which previously was an “an Underweight”.
Price Performance Review of AVNS
On Tuesday, Avanos Medical Inc [NYSE:AVNS] saw its stock fall -0.74% to $12.14. Over the last five days, the stock has lost -5.96%. Avanos Medical Inc shares have fallen nearly -23.74% since the year began. Nevertheless, the stocks have fallen -38.09% over the past one year. While a 52-week high of $25.36 was reached on 01/30/25, a 52-week low of $11.84 was recorded on 04/21/25.
Levels Of Support And Resistance For AVNS Stock
The 24-hour chart illustrates a support level at 12.02, which if violated will result in even more drops to 11.90. On the upside, there is a resistance level at 12.29. A further resistance level may holdings at 12.45.
